Optimized dosing of guideline-directed medical therapies is essential in heart failure with reduced ejection fraction

Int J Cardiol. 2023 Jan 1:370:325-326. doi: 10.1016/j.ijcard.2022.10.137. Epub 2022 Oct 21.

Authors

Christian C Faaborg-Andersen¹, Adrian daSilva-deAbreu², Hector O Ventura³

Affiliations

¹ Department of Internal Medicine, Massachusetts General Hospital, Boston, MA, USA. Electronic address: MDChristianAndersen@gmail.com.
² Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
³ John Ochsner Heart and Vascular Institute, Ochsner Medical Center, New Orleans, LA, USA.

PMID: 36273666
DOI: 10.1016/j.ijcard.2022.10.137

No abstract available

Publication types

Editorial

MeSH terms

Angiotensin Receptor Antagonists
Heart Failure* / diagnosis
Heart Failure* / drug therapy
Humans
Stroke Volume
Ventricular Dysfunction, Left*

Substances

Angiotensin Receptor Antagonists